VTGN
Vistagen Therapeutics
$0.17
+$0.00 (+0.59%)Oct 29, 2026
Key metrics
The numbers that frame VTGN today
- Market cap
- $7.59M
- Gross margin
- 100%
- ROIC
- -1,028.1%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.17
- 52wk High
- $5.14
Growth
Revenue and earnings trend for VTGN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about VTGN
Is Vistagen Therapeutics a good buy?
No. Vistagen Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case.
What is the market capitalization of VTGN?
Vistagen Therapeutics's market capitalization is $7.59M.
What is the 52-week high for VTGN stock?
The 52-week high for Vistagen Therapeutics is $5.14. The current close of $0.17 is 96.7% below that high.
What is the 52-week low for VTGN stock?
The 52-week low for Vistagen Therapeutics is $0.17. The current close of $0.17 is 3.6% above that low.
Does VTGN stock pay dividends?
Vistagen Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for VTGN?
Vistagen Therapeutics's Debt / Equity ratio is 0.03.